Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re Offer for Subscription

1 Apr 2021 10:33

RNS Number : 3119U
Maven Income and Growth VCT 5 PLC
01 April 2021
Β 

Maven Income and Growth VCT 5 PLC (the Company)

Β 

Offer for Subscription

Β 

1 April 2021

Β 

On 23 October 2020, the Company and Maven Income and Growth VCT PLC announced the publication of a joint Prospectus (comprising a securities note, registration document and a summary) in relation to offers for subscription of new ordinary shares of 10p each (together the "Offers" and each an "Offer").

Β 

The Board of the Company today announces that it has received subscriptions up to its fundraising limit of Β£20 million (which includes the full utilisation of its Β£10 million over-allotment facility). Accordingly, its Offer is now closed for further applications.

Β 

The Board of the Company intends that the final allotment in respect of applications for the 2020/2021 tax year will take place today, 1 April 2021, and that a single allotment, in respect of applications for the 2021/2022 tax year, will take place on or before 4 May 2021.

Β 

Downloadable versions of the Prospectus documents are available from the Company's website at www.mavencp.com/vctoffers.

Β 

Any enquiries in respect of the Offer, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

Β 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

Β 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRDKDBNCBKKKQK
Date   Source Headline
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
21st Mar 20254:35 pmRNSNet Asset Value(s)
12th Mar 20254:54 pmRNSAnnual Financial Report
26th Feb 20254:41 pmRNSTransaction in Own Shares
26th Feb 202510:33 amRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:12 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
17th Dec 20243:27 pmRNSDirectorate Change
13th Dec 20242:45 pmRNSUnaudited Net Asset Value
14th Nov 20242:58 pmRNSResult of General Meeting
8th Oct 20245:01 pmRNSTransaction in Own Shares
4th Oct 20244:18 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 20249:47 amRNSIssue of Equity
5th Sep 20242:28 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:36 pmRNSUnaudited Net Asset Value
12th Jul 20244:37 pmRNSTransaction in Own Shares
12th Jul 20244:09 pmRNSHalf-year Report
10th Jul 20245:05 pmRNSTransaction in Own Shares
5th Jul 202412:38 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
9th May 20244:05 pmRNSTransaction in Own Shares
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.